Status:
COMPLETED
Palliative 3-Dimensional Conformal Radiation Therapy in Reducing Radiation Side Effects in Patients With Lung Cancer. ICORG 06-34
Lead Sponsor:
Cancer Trials Ireland
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
RATIONALE: 3-dimensional conformal radiation therapy may lessen side effects caused by palliative radiation therapy and improve the quality of life of patients with lung cancer. PURPOSE: This clinica...
Detailed Description
The primary purpose of this study is to demonstrate that using technically sophisticated 3-dimensional conformal radiation therapy for the palliative treatment of lung cancer patients will result in e...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Karnofsky Performance Status of \> or equal to 40%
- Patients with locally advanced or metastatic small cell or non-small cell lung cancer
- The presence of intra-thoracic symptoms requiring palliative treatment
- WBI (if required) is permitted
- The patient's condition must permit waiting for the 3-dimensional design process to be implemented. This will be at the discretion of the Consultant Physician
- Patients presenting with pleural effusions - provided the pleural effusion does not prevent the reasonably accurate delineation of the target volume
- Intra-thoracic disease requiring palliation must be clearly evident on a diagnostic CT scan
- Life expectancy of at least 3 months (assessed by clinician)
- Provision of written informed consent in line with ICH-GCP guidelines
Exclusion
- In the opinion of the Investigator, any evidence of severe or uncontrolled systematic disease (e.g. unstable or uncompensated respiratory, cardiac, hepatic or renal disease)
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2016
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01176487
Start Date
June 1 2010
End Date
March 1 2016
Last Update
March 31 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
St Luke's Radiation Oncology Network (SLRON)
Dublin, Ireland, 6
2
Galway University Hospital
Galway, Ireland